BARCELONA -- The oral drug deucravacitinib (Sotyktu) passed what is probably its final test as a treatment for psoriatic ...

Journalists can use these 10 tools to examine education data in areas such as student achievement, school segregation and ...

CIRRUS Intelligence has announced that its aviation safety solution, developed, has been selected for presentation at the G7 ...

The diabetic nephropathy market is driven by the growing burden of diabetes and the increasing demand for effective treatments for kidney disease. Advances in therapeutics, including new drug classes ...

In her recent State of the Science address, National Academy of Sciences President Marcia McNutt warned of a “pessimistic ...

Day One officially began on Monday, June 15, 2025, with an automation session chaired by LCGC International’s Pharmaceutical Perspectives columnist, and active member of ChromSoc, Adrian Clarke from ...

As public health data becomes harder to access, journalists and experts at AHCJ25 shared tips and tools for uncovering and ...

Discover Cabaletta Bio's promising CAR T-cell therapy for autoimmune diseases! Durable efficacy, FDA support, and clinical ...

Arrive AI boasts a strong patent portfolio, promising partnerships, and a $40 million cash infusion. Read why we rate ARAI ...

Research findings increasingly indicate close associations between autoimmune thyroid disease and rheumatic disease.

Artificial intelligence can help advisors in concrete ways right now, Michael Kitces and Capital Group's Brock Sutton say.